Literature DB >> 8768499

Mechanisms of the effects of methotrexate.

B N Cronstein1, J T Merrill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8768499

Source DB:  PubMed          Journal:  Bull Rheum Dis        ISSN： 0007-5248


× No keyword cloud information.
  3 in total

1.  Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype.

Authors:  Halima Moncrieffe; Anne Hinks; Simona Ursu; Laura Kassoumeri; Angela Etheridge; Mike Hubank; Paul Martin; Tracey Weiler; David N Glass; Susan D Thompson; Wendy Thomson; Lucy R Wedderburn
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

2.  Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.

Authors:  Raphael Sanches Peres; Foo Y Liew; Jhimmy Talbot; Vanessa Carregaro; Rene D Oliveira; Sergio L Almeida; Rafael F O França; Paula B Donate; Larissa G Pinto; Flavia I S Ferreira; Diego L Costa; Daniel P Demarque; Dayana Rubio Gouvea; Norberto P Lopes; Regina Helena C Queiroz; Joao Santana Silva; Florencio Figueiredo; Jose Carlos Alves-Filho; Thiago M Cunha; Sérgio H Ferreira; Paulo Louzada-Junior; Fernando Q Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

3.  Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.

Authors:  Laura B Ramsey; Frank M Balis; Maureen M O'Brien; Kjeld Schmiegelow; Jennifer L Pauley; Archie Bleyer; Brigitte C Widemann; David Askenazi; Sharon Bergeron; Anushree Shirali; Stefan Schwartz; Alexander A Vinks; Jesper Heldrup
Journal:  Oncologist       Date:  2017-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.